CompanyNCNANasdaqEdinburgh, X0

NuCana plc

NuCana develops ProTide-based chemotherapy agents for cancer.

SEC EDGAR ClinicalTrials.gov nucana.com

6-KSep 30Latest SEC filing

Jul 23Latest story

July 2026

NuCana's NuTide:303 trial for NUC-3373 combos terminated; results posted with 19 enrolled

Jul 23Trial updatefosifloxuridine nafalbenamide NuCana plc